Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1983 Feb;39(2):565–568. doi: 10.1128/iai.39.2.565-568.1983

Immunoglobulin G subclass restriction of antibodies against hepatitis B surface antigen.

A Morell, B Roth-Wicky, F Skvaril
PMCID: PMC347988  PMID: 6832810

Abstract

Immunoglobulin G (IgG) antibodies against hepatitis B surface antigen were found to be restricted to subclasses IgG1 and IgG3 in serum samples of 17 individuals. Quantitative determinations showed that in 10 samples the minor serum subclass IgG3 contained more antibodies than the predominant subclass IgG1. Ranges of concentrations were between 0.72 and 16.50 micrograms/ml for IgG3 antibodies and between 0.55 and 6.19 micrograms/ml for antibodies of subclass IgG1.

Full text

PDF
565

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beck O. E. Distribution of virus antibody activity among human IgG subclasses. Clin Exp Immunol. 1981 Mar;43(3):626–632. [PMC free article] [PubMed] [Google Scholar]
  2. Cantarero L. A., Butler J. E., Osborne J. W. The adsorptive characteristics of proteins for polystyrene and their significance in solid-phase imunoassays. Anal Biochem. 1980 Jul 1;105(2):375–382. doi: 10.1016/0003-2697(80)90473-x. [DOI] [PubMed] [Google Scholar]
  3. Devey M. E., Voak D. A critical study of the IgG subclasses of Rh anti-D antibodies formed in pregnancy and in immunized volunteers. Immunology. 1974 Dec;27(6):1073–1079. [PMC free article] [PubMed] [Google Scholar]
  4. Krugman S., Overby L. R., Mushahwar I. K., Ling C. M., Frösner G. G., Deinhardt F. Viral hepatitis, type B. Studies on natural history and prevention re-examined. N Engl J Med. 1979 Jan 18;300(3):101–106. doi: 10.1056/NEJM197901183000301. [DOI] [PubMed] [Google Scholar]
  5. Oxelius V. A., Laurell A. B., Lindquist B., Golebiowska H., Axelsson U., Björkander J., Hanson L. A. IgG subclasses in selective IgA deficiency: importance of IgG2-IgA deficiency. N Engl J Med. 1981 Jun 11;304(24):1476–1477. doi: 10.1056/NEJM198106113042408. [DOI] [PubMed] [Google Scholar]
  6. Pike I. M., Yount W. J., Puritz E. M., Roberts H. R. Immunochemical characterization of a monoclonal G4,lambda human antibody to factor IX. Blood. 1972 Jul;40(1):1–10. [PubMed] [Google Scholar]
  7. Prince A. M., Szmuness W., Mann M. K., Vyas G. N., Grady G. F., Shapiro F. L., Suki W. N., Freidman E. A., Avram M. M., Stenzel K. H. Hepatitis B immune globulin: final report of a controlled, multicenter trial of efficacy in prevention of dialysis-associated hepatitis. J Infect Dis. 1978 Feb;137(2):131–144. doi: 10.1093/infdis/137.2.131. [DOI] [PubMed] [Google Scholar]
  8. Riesen W. F., Skvaril F., Braun D. G. Natural infection of man with group A streptococci. Levels; restriction in class, subclass, and type; and clonal appearance of polysaccharide-group-specific antibodies. Scand J Immunol. 1976;5(4):383–390. doi: 10.1111/j.1365-3083.1976.tb00292.x. [DOI] [PubMed] [Google Scholar]
  9. Spiegelberg H. L. Biological activities of immunoglobulins of different classes and subclasses. Adv Immunol. 1974;19(0):259–294. doi: 10.1016/s0065-2776(08)60254-0. [DOI] [PubMed] [Google Scholar]
  10. Vandvik B., Natvig J. B., Wiger D. IgG1 subclass restriction of oligoclonal IgG from cerebrospinal fluids and brain extracts in patients with multiple sclerosis and subacute encephalitides. Scand J Immunol. 1976;5(4):427–436. doi: 10.1111/j.1365-3083.1976.tb00297.x. [DOI] [PubMed] [Google Scholar]
  11. Yount W. J., Dorner M. M., Kunkel H. G., Kabat E. A. Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers. J Exp Med. 1968 Mar 1;127(3):633–646. doi: 10.1084/jem.127.3.633. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES